INTRODUCTION
The cleft palate is an abnormality in the embryogenesis period, characterized by a loss of fusion of palatal shelves (1) . The lip and palate clefts are found in one in 700 live births worldwide (17) . About 70% of all lip and palate clefts are nonsyndromic, while the remaining 30% are associated with other hereditary abnormalities. The largest number of nonsyndromic lip and palate cleft is found in North American Indian and Asian populations, where incidence ranges from one to 500 in live birth children. The interaction of teratogenic factors and genes is important for the development of the lip and palate. In the case of clefts, the effects of different locuses have been shown in chromosomes 1, 2, 3, 4, 6, 18, 19 and 21, but the main teratogenic factors are maternal stress, alcohol use, smoking and the effect of folic acid in pregnancy (16) .
In recent years, attention has been paid to specific genes and proteins in the process of cleft development, which directly affects the morphological processes of tissues (21) . Runx2 belongs to the Runx gene family, which is responsible for encoding transcription factors, mainly by engaging in cell differentiation (4) . There are three distinct Runx genes. Runx1 is involved in hematopoiesis, Runx2 in sceletogenesis, but the role of Runx3 has not been fully understood (18) . Runx2 primary importance is in osteoblast differentiation and cartilage hypertrophy in the primary palate, as well as Runx2 is associated with cell migration and bone vascularisation (3) . The Runx2 gene in the bone mainly promotes mineralization and stimulates osteoblast proliferation (6) . Researches have shown the effect of the osteoblast specific transcription factor Runx2 on the differentiation of mesenchymal stem cells to primary osteoblasts in cartilage tissue (22) . Runx2 in immature chondrocytes promote cartilage hypertrophy (13) . Runx2 are expressed mainly by hypertrophic perichondrocytes, which indicate the initial ossification process (8) . Runx2 has also been shown to play a role in osteoarthritis, affecting mesenchymal cells. This gene promotes the activity of osteoblasts and chondrocytes, thereby promoting ossification processes (19) . Wnt3 is a determinant gene of signaling molecules that belongs to the Wnt gene family and regulates various morphogenetic processes, including cellular polarity detection, differentiation and migration (14) . In the embryogenesis period, the role of Wnt3 is in bone mass formation through mesenchymal cell proliferation, regeneration of stem cells, and stimulation of preosteoblastic replication. In this developmental period, Wnt3 is believed to be involved in inhibition of osteoblast and osteocyte apoptosis and stimulation of developing the osteoblasts. The Wnt3 gene affects mesenchyme, causing it to form into osteoblasts (9) . The Wnt3 gene in in cartilage tissue inhibits its proliferation and triggers the process of differentiation of the chondrocyte, which later, through involvement of other genes, will contribute to the ossification process (7) . Recent studies have shown the direct activating effect of the Wnt3 gene signaling molecules on the active component of T cell transcription factor 1 (TCF1),which is a Runx2 gene promoter, thus activating the Runx2 gene in mesenchymal cells (5) . In recent years, the Wnt3 gene is increasingly associated with lip and palate cleft, but the involvement of the gene in the pathogenesis mechanism is not completely clear (15) . Osteoprotegerin (OPG) is a protein belonging to the Tumor Necrosis Factor (TNF) gene family. Mostly, these proteins are synthesized by osteoblasts and play an important role in bone remodeling (11) . OPG binds to the receptor activator of nucleic factor kappa B ligand (RANKL) to form the OPG / RANKL complex, prevents it from binding to the receptor activator of nuclear factor kappa B (RANK), which is present on the osteoclast cell surface, thereby inhibiting osteoclast differentiation and proliferation (20) . OPG and RANKL play a primary role in bone metabolism process. Expression of OPG synthesis increases OPG / RANKL complex ratio, resulting in reduced bone remodeling (11) . Tissue stress plays an important role in the inhibition of osteoclast and bone proliferation. Tissue stress is carried out through bone tissue metabolism, where OPG synthesis increases. In various studies, bone tissue stress is associated with tissue impairment, ultrasound, gravitation and mechanical damage. The increased OPG / RANKL ratio is associated with Paget's disease, benign and malignant bone tumors, metastatic processes, rheumatoid arthritis and postmenopausal osteoporosis (10) . The effect of OPG on the development of palate clefts has been studied very little so far. OPG expression in palate bone tissues in children with lip and palate clefts has been demonstrated, suggesting osteoclast dysregulation in the morpho-pathogenetic process of the cleft (12) . The WNT gene is believed to increase the level of OPG by reducing osteoclastogenesis and increasing the build-up of bone tissue in the cleft affected tissues (2) .
AIM OF THE STUDY
The aim of the work was to evaluate the expression of Runx2, Wnt3 and OPG in palate bone and nasal cartilage for children with cleft palate. 
MATERIAL AND METHODS

RESULTS
The expression of Runx2, Wnt3, and OPG positive structures in the tissues was variable. Compared to bone tissue, the detection of genes and signal molecules was better observed in cartilage tissue, except in two cases where we observed moderate to numerous and numerous Runx2, Wnt3 and OPG positive cells in the bone tissue (see Table 1 ). Runx2 expression was observed in five patient bone tissue and six cartilage tissue samples. From Runx2 positive bone tissue samples, in one case, we observed occasional, in two cases-few, in one case-moderate to numerous and in one case-numerous positive osteocytes (see Figure 1) . On the other hand, in cartilage tissue, in two cases we observed occasional, in one case-few to moderate, in two cases-moderate, and in one case, numerous positive chondrocytes (see Figure 2) . A significant difference in Wnt3 expression was observed between the bones and cartilage. Wnt3 expressing chondrocytes were observed in all samples, in which one case we observed occasional, in three cases few, in one case-moderate and in six cases, numerous Wnt3 positive cartilage cells (see Figure 3 and Figure 6 ). The expression of the gene in the bone was observed in nine cases, which contained mostly occasional or few positive structures, except in three cases where Wnt3 was marked by few to moderate and in two casesnumerous positive osteocytes (see Figure 4) . OPG expression was observed in all samples, but expression in cartilage was more pronounced. In the cartilage in seven cases, there were numerous positive chondrocytes observed (see Figure 5 ), in one casemoderate to numerous, in two cases -moderate, and in one -few to moderate amount of chondrocytes. In the bones OPG was expressed variably. In four cases, we observed occasional to few, in one case -few to moderate, in one case-moderate to numerous, and in four cases, numerous positive bone cells.
DISCUSSION
In the bone, the Runx2 gene mainly promotes bone mineralization and osteoblast proliferation, thereby promoting bone modulation (6) . The expression of this gene in cartilage shows an initial ossification (13) . By promoting ossification, the development of the bone is also enhanced in the cleft palate. In our study, the expression of the Runx2 gene in bone was practically not observed, but the expression of gene in cartilage was weak, indicating a reduced mineralization of the tissues, but more active cartilage proliferation. In our study, the presence of Wnt3 gene was observed in cartilage tissue, which indicates initial ossification in the cartilage. It has been shown that the Wnt3 gene mainly inhibits cartilage proliferation and induces chondrocyte differentiation (7), promoting bone development. Compared to the cartilage, the expression of Wnt3 in the bone was convincingly weaker, suggesting a weaker osteoblast involvement, thus weak bone mineralization. Studies have shown that the presence of the Wnt3 gene in osteoblast shows its proliferation (9) . OPG binds to the RANKL ligand to form the OPG / RANKL complex, in a result RANKL cannot bind to the RANK receptor located on the surface of the osteoclast cell, thereby inhibiting osteoclast differentiation and proliferation (20) . The presence of OPG in the tissues indicates a reduction of cartilage and bone tissue reabsorption, promoting tissue development. In our study, we observed a significant presence of OPG, both in bone and in cartilage, indicative of compensatory tissue proliferation. We believe this is an essential early compensating mechanism in the case of cleft palate. Since the expression of Wnt3 and OPG in cartilage tissue was more pronounced in comparison to bone tissue, except in two cases where in the bone all of these genes and proteins were observed in moderate and numerous osteocytes, therefore, we assume that tissue proliferation plays a more important role in the cleft palate, but tissue mineralization has less importance.
CONCLUSIONS
Increased cartilage tissue secretion of Runx2, Wnt3 genes and OPG proteins, proves probably the compensatory tissue capacity in case of clefts. In the case of cleft lip and palate, the high expression of Wnt3 and OPG and less expressed Runx2 could indicate significant tissue proliferation predominance over mineralization and ossification processes. 
